Innovative Immunotherapy Solution for Solid TumorTreatments
Harnessing IdeS-Cleaved Antibodies to Amplify Anti-Cancer Responses
Transforming Cancer Treatment through Advanced Immunotherapy
Innovative Immunotherapy Solutions
At Immune Propulsion, we focus on utilizing IdeS-cleaved antibodies to enhance existing anti-cancer monoclonal antibodies. Our research emphasizes the potential of these innovative approaches in tackling solid tumors and advancing immunotherapy for cancer.
Harnessing Host Antitumor Antibodies
We empower the immune system to work synergistically with host antitumor antibodies, utilizing data-driven methodologies aimed at amplifying immune responses against cancer. Collaboration with researchers and medical professionals is key to unlocking these transformative therapies.